Pharmaceutical Preparations · CIK 1061983
CYTOKINETICS INC develops and commercializes drug products, with recent FDA approval for MYQORZO
Comparable business profile · signals at a glance
In the 90 days to Mar 31, 2026: 5 sold $9.1M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 31, 2026 | Callos AndrewEVP, Chief Commercial Officer | Sell | 3,639 | $65.00 | $237K |
| Mar 18, 2026 | Callos AndrewEVP, Chief Commercial Officer | Sell | 1,930 | $62.07 | $120K |
| Mar 17, 2026 | Blum Robert IPresident & CEO | Sell | 23,928 | $62.15 | $1.5M |
| Mar 17, 2026 | Blum Robert IPresident & CEO | Sell | 12,673 | $62.15 | $788K |
| Mar 17, 2026 | Malik Fady IbrahamEVP Research & Development | Sell | 7,636 | $62.15 | $475K |
| Mar 17, 2026 | Callos AndrewEVP, Chief Commercial Officer | Sell | 5,626 | $62.15 | $350K |
| Mar 17, 2026 | Lee SungEVP, Chief Financial Officer | Sell | 4,935 | $62.15 | $307K |
| Mar 17, 2026 | Malik Fady IbrahamEVP Research & Development | Sell | 4,397 | $62.15 | $273K |
| Mar 17, 2026 | Callos AndrewEVP, Chief Commercial Officer | Sell | 2,916 | $62.15 | $181K |
| Mar 16, 2026 | Callos AndrewEVP, Chief Commercial Officer | Sell | 1,709 | $61.03 | $104K |
| Mar 9, 2026 | Blum Robert IPresident & CEO | Sell | 7,931 | $60.72 | $482K |
| Mar 9, 2026 | Malik Fady IbrahamEVP Research & Development | Sell | 2,907 | $60.72 | $177K |
| Mar 9, 2026 | Callos AndrewEVP, Chief Commercial Officer | Sell | 2,582 | $60.72 | $157K |
| Mar 5, 2026 | Callos AndrewEVP, Chief Commercial Officer | Sell | 15,000 | $61.87 | $928K |
| Mar 5, 2026 | Callos AndrewEVP, Chief Commercial Officer | Sell | 11,000 | $61.88 | $681K |
| Mar 2, 2026 | Parshall B LynneDirector | Sell | 5,000 | $61.21 | $306K |
| Mar 2, 2026 | Callos AndrewEVP, Chief Commercial Officer | Sell | 886 | $61.62 | $55K |
| Feb 5, 2026 | Callos AndrewEVP, Chief Commercial Officer | Sell | 15,000 | $61.93 | $929K |
| Feb 2, 2026 | Callos AndrewEVP, Chief Commercial Officer | Sell | 886 | $62.10 | $55K |
| Jan 5, 2026 | Callos AndrewEVP, Chief Commercial Officer | Sell | 15,000 | $60.28 | $904K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.